Alzamend Neuro, Inc.·4

Mar 24, 7:30 AM ET

Katzoff David J 4

4 · Alzamend Neuro, Inc. · Filed Mar 24, 2025

Insider Transaction Report

Form 4
Period: 2025-03-21
Katzoff David J
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2025-03-21$1.01/sh+5,000$5,0485,540 total

Documents

1 file
  • 4
    marketforms-68905.xmlPrimary

    PRIMARY DOCUMENT